Business

In this article 4523.T-JP BIIB Follow your favorite stocksCREATE FREE ACCOUNT The Alzheimer’s drug Leqembi is seen in this undated handout image obtained by Reuters on Jan. 20, 2023. Eisai | Reuters The new Alzheimer‘s antibody treatment Leqembi could cost Medicare up to $5 billion per year, according to research published in a leading medical
0 Comments